Class of 2024 celebrated at Carnegie Hall Commencement

More than 300 expected graduates in received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony May 16 at Carnegie Hall.

Dr. Myles Wolf Appointed Chair of Medicine at Weill Cornell Medicine

Dr. Myles Wolf will lead the institutions’ largest clinical and academic department, overseeing 16 divisions and nearly 2,250 physicians and scientists.

Around Cornell

Cross-campus collaboration unlocks health systems M.Eng. pathway

The Department of Population Health Sciences at Weill Cornell Medicine and the Systems Engineering program in Cornell Engineering have teamed up to create a Health Systems Engineering pathway in the existing Master of Engineering program offered by Systems Engineering.

Around Cornell

GoT-ChA: New tool reveals how gene mutations affect cells

Researchers have developed an advanced method for revealing how gene mutations disrupt the normal packaging of DNA, which can lead to malignancy.

Common type of fiber may trigger bowel inflammation

Inulin, a type of fiber found in certain plant-based foods and fiber supplements, causes inflammation in the gut and exacerbates inflammatory bowel disease in a preclinical model, according to a new study.

Resident-to-resident aggression common in assisted living

One in six assisted living facility residents is subject to verbal, physical or other aggression by a fellow resident in a typical month, according to the first large-scale study of the phenomenon.

Four Cornell professors elected to national academy

Mario Herrero, Timothy Ryan, M.S. ’86, Ph.D. ’89, Steven Strogatz and Peter Wolczanski are Cornell’s 2024 electees to the National Academy of Sciences, the academy announced April 30 at the close of its 161st annual meeting.

Prevalent heart conditions may differ in low, high-income nations

Early onset heart failure is alarmingly common in urban Haiti – over 15-fold higher than previously estimated – according to a study conducted by Weill Cornell Medicine researchers in partnership with the Haitian medical organization GHESKIO.

Solving the riddle of sphingolipids in coronary artery disease

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.